{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:20:47Z","timestamp":1785842447395,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":5617,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1093\/annonc\/mdh651","type":"journal-article","created":{"date-parts":[[2004,7,27]],"date-time":"2004-07-27T19:42:35Z","timestamp":1090957355000},"page":"i7-i13","source":"Crossref","is-referenced-by-count":41,"special_numbering":"S1","title":["Genetic alterations in hereditary breast cancer"],"prefix":"10.1016","volume":"15","author":[{"given":"G.","family":"Cipollini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tommasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Paradiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aretini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bonatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Schittulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tancredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Caligo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdh651_bb0010","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","article-title":"Linkage of early-onset familial breast cancer to chromosome 17q21","volume":"250","author":"Hall","year":"1990","journal-title":"Science"},{"key":"10.1093\/annonc\/mdh651_bb0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/bcr290","article-title":"More breast cancer genes?","volume":"3","author":"Hopper","year":"2001","journal-title":"Breast Cancer Res"},{"key":"10.1093\/annonc\/mdh651_bb0020","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/jnci\/90.14.1039","article-title":"The concise handbook of family cancer syndromes. Familial Cancer Program","volume":"90","author":"Lindor","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdh651_bb0025","first-page":"6094","article-title":"Follow-up study of twenty-four families with Li\u2013Fraumeni syndrome","volume":"51","author":"Garber","year":"1991","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdh651_bb0030","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1126\/science.286.5449.2528","article-title":"Heterozygous germ line hCHK2 mutations in Li\u2013Fraumeni syndrome","volume":"286","author":"Bell","year":"1999","journal-title":"Science"},{"key":"10.1093\/annonc\/mdh651_bb0035","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A single ataxia telangiectasia gene with a product similar to PI-3 kinase","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"key":"10.1093\/annonc\/mdh651_bb0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1086\/301673","article-title":"Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations","volume":"62","author":"Telatar","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdh651_bb0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jnci\/93.2.121","article-title":"Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries","volume":"93","author":"Olsen","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdh651_bb0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ng0198-38","article-title":"Peutz\u2013Jeghers syndrome is caused by mutations in a novel serine threonine kinase","volume":"18","author":"Jenne","year":"1998","journal-title":"Nat Genet"},{"key":"10.1093\/annonc\/mdh651_bb0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/(SICI)1098-1004(1999)13:6<476::AID-HUMU7>3.0.CO;2-2","article-title":"Novel mutations in the LKB1\/STK11 gene in Dutch Peutz\u2013Jeghers families","volume":"13","author":"Westerman","year":"1999","journal-title":"Hum Mutat"},{"key":"10.1093\/annonc\/mdh651_bb0060","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1053\/gast.2000.20228","article-title":"Very high risk of cancer in familial Peutz\u2013Jeghers syndrome","volume":"119","author":"Giardiello","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1093\/annonc\/mdh651_bb0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1093\/annonc\/mdh651_bb0070","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"10.1093\/annonc\/mdh651_bb0075","first-page":"3168","article-title":"BRCA1 is a 220 kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner","volume":"56","author":"Chen","year":"1996","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdh651_bb0080","first-page":"5485","article-title":"Nuclear location and cell cycle regulation of the BRCA2 protein","volume":"57","author":"Bertwistle","year":"1997","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdh651_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-5793(96)01312-9","article-title":"From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair","volume":"400","author":"Callebaut","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1093\/annonc\/mdh651_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2","volume":"108","author":"Venkitaraman","year":"2002","journal-title":"Cell"},{"key":"10.1093\/annonc\/mdh651_bb0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1383-5742(02)00063-7","article-title":"BRCA1 and differentiation","volume":"512","author":"Kubista","year":"2002","journal-title":"Mutat Res"},{"key":"10.1093\/annonc\/mdh651_bb0100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1073\/pnas.012584499","article-title":"Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium","volume":"99","author":"Thompson","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdh651_bb0105","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1038\/sj.onc.1203968","article-title":"Lessons learned from BRCA1 and BRCA2","volume":"19","author":"Zheng","year":"2000","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/mdh651_bb0110","first-page":"593","article-title":"Telomeres and genomic damage repair. Their implication in human pathology","volume":"62","author":"Perez Mdel","year":"2002","journal-title":"Medicina"},{"key":"10.1093\/annonc\/mdh651_bb0115","first-page":"1673","article-title":"Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13","volume":"10","author":"Collins","year":"1995","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/mdh651_bb0120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/ng0396-298","article-title":"Growth retardation and tumour inhibition by BRCA1","volume":"12","author":"Holt","year":"1996","journal-title":"Nat Genet"},{"key":"10.1093\/annonc\/mdh651_bb0125","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdh651_bb0130","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/jmg.38.12.824","article-title":"Steering Committee of the Breast Cancer Information Core (BIC) Consortium: Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1","volume":"38","author":"Eng","year":"2001","journal-title":"J Med Genet"},{"key":"10.1093\/annonc\/mdh651_bb0135","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1038\/sj.onc.1205685","article-title":"Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families","volume":"21","author":"Gad","year":"2002","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/mdh651_bb0140","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/hmg\/ddg120","article-title":"Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast\/ovarian cancer families","volume":"12","author":"Montagna","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1093\/annonc\/mdh651_bb0145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/jmg.39.4.225","article-title":"Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility","volume":"39","author":"de Jong","year":"2002","journal-title":"J Med Genet"},{"key":"10.1093\/annonc\/mdh651_bb0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0027-5107(02)00224-5","article-title":"Recombinational DNA repair and human disease","volume":"509","author":"Thompson","year":"2002","journal-title":"Mutat Res"},{"key":"10.1093\/annonc\/mdh651_bb0155","first-page":"2440","article-title":"Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility","volume":"63","author":"Fu","year":"2003","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdh651_bb0160","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jama.279.12.922","article-title":"BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history","volume":"279","author":"Malone","year":"1998","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdh651_bb0165","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdh651_bb0170","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh651_bb0175","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.med.49.1.425","article-title":"Hereditary breast cancer","volume":"49","author":"Ellisen","year":"1998","journal-title":"Annu Rev Med"},{"key":"10.1093\/annonc\/mdh651_bb0180","first-page":"1041","article-title":"A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families","volume":"60","author":"Peelen","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdh651_bb0185","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/S0959-8049(01)00223-4","article-title":"A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer","volume":"37","author":"Einbeigi","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdh651_bb0190","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1054\/bjoc.1999.0963","article-title":"Identification of a founder BRCA2 mutation in Sardinia","volume":"82","author":"Pisano","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdh651_bb0195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/humu.1167","article-title":"Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast\/ovarian cancer","volume":"18","author":"Baudi","year":"2001","journal-title":"Hum Mutat"},{"key":"10.1093\/annonc\/mdh651_bb0200","first-page":"1483","article-title":"BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations","volume":"13","author":"Caligo","year":"1996","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/mdh651_bb0205","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<386::AID-IJC13>3.0.CO;2-6","article-title":"Familial breast cancer in the family-cancer database","volume":"77","author":"Hemminki","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdh651_bb0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0960-7404(02)00016-6","article-title":"Risk estimation for breast cancer development; a clinical perspective","volume":"10","author":"Sakorafas","year":"2002","journal-title":"Surg Oncol"},{"key":"10.1093\/annonc\/mdh651_bb0215","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases","volume":"83","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdh651_bb0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/301903","article-title":"Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients","volume":"63","author":"Fodor","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdh651_bb0225","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng0596-117","article-title":"A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes","volume":"13","author":"Thorlacius","year":"1996","journal-title":"Nat Genet"},{"key":"10.1093\/annonc\/mdh651_bb0230","first-page":"678","article-title":"Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium","volume":"52","author":"Easton","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdh651_bb0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdh651_bb0240","series-title":"Biotechniques","first-page":"22","article-title":"Statistical modeling and visualization of molecular profiles in cancer","author":"Scharpf","year":"2003"},{"key":"10.1093\/annonc\/mdh651_bb0245","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","article-title":"BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes","volume":"20","author":"Berry","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh651_bb0250","first-page":"107S","article-title":"Immunophenotypic and pathologic differences between BRCA1 and BRCA2 herditary breast cancers","volume":"18","author":"Phillips","year":"2000","journal-title":"J Clin Onco"},{"key":"10.1093\/annonc\/mdh651_bb0255","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","article-title":"The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2","volume":"20","author":"Lakhani","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh651_bb0260","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10 000 individuals","volume":"20","author":"Frank","year":"2002","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419473997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419473997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/15\/suppl_1\/i7\/456308\/mdh651.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T15:52:09Z","timestamp":1589471529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419473997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":51,"alternative-id":["S0923753419473997"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdh651","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}